Global Hemophilia Market 2014-2018

Global Hemophilia Market 2014-2018

Category : Pharmaceuticals
Published On : November  2013
Pages : 61


------------ Or -------------

TechNavio's analysts forecast the Global Hemophilia market to grow at a CAGR of 6.07 percent over the period 2013-2018. One of the key factors contributing to this market growth is the development of new hemophilia therapeutics. The Global Hemophilia market has also been witnessing the increase in technological innovations. However, the high cost of hemophilia therapeutics could pose a challenge to the growth of this market. 
TechNavio's report, the Global Hemophilia Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Hemophilia market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Baxter International Inc., Bayer AG., Novo Nordisk A/s-b., and Pfizer Inc.
Other vendors mentioned in the report are Biogen Idec, Inc., CSL Behring LLC., Grifols S.A, Inspiration Biopharmaceuticals Inc., Kedrion Biopharma Inc., Octapharma AG., and Swedish Orphan Biovitrum AB.
Key questions answered in this report: 
What will the market size be in 2016/2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.



01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

07. Hemophilia Product Pipeline

07.1 Five Forces Analysis

08. Market Segmentation of Hemophilia Market by Type

08.1 Overview

08.1.1 Hemophilia A

08.1.2 Hemophilia B

08.1.3 Inhibitors

08.1.4 Von WilleBrand Disease

08.2 Global Hemophilia A Market

08.2.1 Market Size and Forecast

08.3 Global Hemophilia B Market

08.3.1 Market Size and Forecast

08.4 Global Hemophilia Inhibitors Market

08.4.1 Market Size and Forecast

08.5 Global von Willebrand Disease Market

08.5.1 Market Size and Forecast

09. Geographical Segmentation

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

17.1 Competitive Scenario

17.1.1 Key News

17.1.2 Mergers and Acquisitions

17.2 Market Share Analysis 2013

17.3 Prominent Vendors

18. Key Vendor Analysis

18.1 Baxter International Inc.

18.1.1 Business Overview

18.1.2 Business Segmentation

18.1.3 Key Information

18.1.4 SWOT Analysis

18.2 Novo Nordisk A/S.

18.2.1 Business Overview

18.2.2 Business Segmentation

18.2.3 Key Information

18.2.4 SWOT Analysis

18.3 Bayer AG

18.3.1 Business Overview

18.3.2 Business Segmentation

18.3.3 Key Information

18.3.4 SWOT Analysis

18.4 Pfizer Inc.

18.4.1 Business Overview

18.4.2 Business Segmentation

18.4.3 Key Information

18.4.4 SWOT Analysis

19. Other Reports in this Series

List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Global Hemophilia Market 2013-2018 (US$ billion)

Exhibit 3: Global Hemophilia market-Segmentation by Types

Exhibit 4: Global Hemophilia Market By Type 2013

Exhibit 5: Global Hemophilia Market By Type 2013 (US$billion)

Exhibit 6: Global Hemophilia A Therapeutics Market 2013-2018 (US$billion)

Exhibit 7: Global Hemophilia B Therapeutics Market 2013-2018 (US$billion)

Exhibit 8: Global Hemophilia Inhibitors Market 2013-2018

Exhibit 9: Global von Willebrand Disease Market 2013-2018 (US$ billion)

Exhibit 10: Global Hemophilia Market by Geographical Segmentation 2013

Exhibit 11: Global Hemophilia Market by Vendor Segmentation 2013

Exhibit 12: Business Segmentation of Baxter International Inc.

Exhibit 13: Business Segmentation of Novo Nordisk A/S

Exhibit 14: Business Segmentation of Baxter International Inc.

Exhibit 15: Business Segmentation of Pfizer Inc.



Enquiry Before Buy